astragaloside a has been researched along with Glomerulonephritis, Membranous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Deng, Y; Fan, J; Wang, L; Zhang, M; Zheng, R; Zhong, Y; Zhu, R | 1 |
1 other study(ies) available for astragaloside a and Glomerulonephritis, Membranous
Article | Year |
---|---|
Astragaloside IV attenuates complement membranous attack complex induced podocyte injury through the MAPK pathway.
Topics: Actin Cytoskeleton; Animals; Astragalus propinquus; Cell Line; Complement Membrane Attack Complex; Cytoprotection; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glomerulonephritis, Membranous; Immunohistochemistry; Kidney Glomerulus; L-Lactate Dehydrogenase; MAP Kinase Signaling System; Mice; Phosphorylation; Podocytes; Protective Agents; Proteinuria; Saponins; Time Factors; Triterpenes | 2012 |